HHS has launched a new a conscience and religious freedom division in its Office for Civil Rights. Agency officials said it was in response to increased complaints that providers' religious beliefs were not being respected in healthcare settings.
Pharmaceutical stocks dipped Thursday following the announcement that four large health systems will partner to create a not-for-profit generic drug company.
MACRA's approach to reimbursing physicians is here, but many doctors and administrators are still trying to get a handle on how it works. Read on for tips on how to deal with this major change to the Medicare payment system.
Intermountain Healthcare, Ascension, SSM Health and Trinity Health have joined forces to create a generic-drug company to create cheaper and more available alternatives than they can now obtain on the market.
Health insurer Aetna has agreed to pay $17 million to settle claims that it breached the privacy of thousands of customers who take HIV medications.
In a coordinated, bipartisan letter, the nation's governors made more than two dozen recommendations to President Donald Trump and Congress to bolster the fight against the opioid crisis.
UnitedHealth Group's 2017 revenue surpassed $200 billion, while its profit more than doubled. On top of that, the No. 1 insurer will reap an extra $1.7 billion in 2018 earnings thanks to the Trump administration's tax overhaul.
The interoperability rule would deal with some provisions of the 21st Century Cures Act, including health information networks' use of a framework for data transfer.
Lowe's employees are some of the 1 million people from self-insured employers and health plans who are customers of Accolade, which helps guide patients through the healthcare system.
About 91% of the ACOs in non-risk bearing tracks in 2016 would have saved an additional $966 million overall if they were in a contract with downside risk, according to an Avalere Health analysis released Thursday.
Healthcare has a cost problem. No one disputes that. But what many would dispute is the assertion that rapidly rising drug prices are the root cause of the problem. They are, as the latest data from the CMS and major hospital systems clearly show.